243 related articles for article (PubMed ID: 35188675)
1. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
Zhang L; Hall M; Lam SK
Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
[TBL] [Abstract][Full Text] [Related]
2. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
3. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: Vagus nerve stimulation and medical treatment cohorts.
Zhang L; Wu JY; Lam SK
Epilepsy Behav; 2021 Oct; 123():108281. PubMed ID: 34509035
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term survival with continued medical therapy, vagus nerve stimulation, and cranial epilepsy surgery in paediatric patients with drug-resistant epilepsy in the USA: an observational cohort study.
Zhang L; Hall M; Lam SK
Lancet Child Adolesc Health; 2023 Jul; 7(7):455-462. PubMed ID: 37276875
[TBL] [Abstract][Full Text] [Related]
6. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
[TBL] [Abstract][Full Text] [Related]
7. Disparities in pediatric drug-resistant epilepsy care.
LoPresti MA; Zhang L; Lam S
Childs Nerv Syst; 2023 Jun; 39(6):1611-1617. PubMed ID: 36797496
[TBL] [Abstract][Full Text] [Related]
8. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
[TBL] [Abstract][Full Text] [Related]
9. Comparison of traditional and closed loop vagus nerve stimulation for treatment of pediatric drug-resistant epilepsy: A propensity-matched retrospective cohort study.
Muthiah N; Akwayena E; Vodovotz L; Sharma N; Jeong JH; White GE; Abel TJ
Seizure; 2022 Jan; 94():74-81. PubMed ID: 34872020
[TBL] [Abstract][Full Text] [Related]
10. Development of a clinical model to predict vagus nerve stimulation response in pediatric patients with drug-resistant epilepsy.
Muthiah N; Mallela AN; Vodovotz L; Sharma N; Akwayena E; Pan E; Welch W; Ibrahim GM; Abel TJ
J Neurosurg Pediatr; 2023 May; 31(5):476-483. PubMed ID: 36805960
[TBL] [Abstract][Full Text] [Related]
11. Favorable combinations of antiseizure medication with vagus nerve stimulation to improve health-related quality of life in patients with epilepsy.
Sauer V; Glaser M; Ellwardt E; Saryyeva A; Krauss JK; Ringel F; Groppa S; Winter Y
Epilepsy Behav; 2024 Jan; 150():109562. PubMed ID: 38071825
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of vagus nerve stimulation and antiseizure medication.
Winter Y; Sandner K; Glaser M; Ciolac D; Sauer V; Ziebart A; Karakoyun A; Chiosa V; Saryyeva A; Krauss J; Ringel F; Groppa S
J Neurol; 2023 Oct; 270(10):4978-4984. PubMed ID: 37368131
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the effectiveness of vagus nerve stimulation for pediatric drug-resistant epilepsies secondary to nonaccidental trauma.
Muthiah N; Joseph B; Varga G; Vodovotz L; Sharma N; Abel TJ
Childs Nerv Syst; 2023 May; 39(5):1201-1206. PubMed ID: 36602582
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.
Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y
Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359
[TBL] [Abstract][Full Text] [Related]
16. Effect of vagus nerve stimulation on emergency department utilization in children with drug-resistant epilepsy: a retrospective cohort study.
Muthiah N; Reecher HM; Abel TJ
J Neurosurg Pediatr; 2024 Jun; ():1-8. PubMed ID: 38905712
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model.
Chan HY; Wijnen BFM; Majoie MHJM; Evers SMAA; Hiligsmann M
Epilepsia; 2022 Mar; 63(3):641-651. PubMed ID: 34967942
[TBL] [Abstract][Full Text] [Related]
18. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
Camp C; Smithson WH; Bunker M; Burke T; Hughes D
Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
[TBL] [Abstract][Full Text] [Related]
19. Vagus nerve stimulation in refractory idiopathic generalised epilepsy: An Irish retrospective observational study.
Peña-Ceballos J; Moloney PB; Valentin A; O'Donnell C; Colleran N; Liggan B; Staunton-Grufferty B; Ennis P; Grogan R; Mullins G; Costello DJ; Doherty CP; Sweeney KJ; El Naggar H; Kilbride RD; Widdess-Walsh P; O'Brien D; Delanty N
Seizure; 2023 Nov; 112():98-105. PubMed ID: 37778300
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal EpiTrack assessment of executive functions following vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
Lähde N; Basnyat P; Raitanen J; Lehtimäki K; Rosti-Otajärvi E; Peltola J
Epilepsia Open; 2024 Feb; 9(1):150-163. PubMed ID: 37897151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
